Cell death protein
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
*CED-1 | *CED-1 | ||
| - | **[[1npu]] – mCED-1 extracellular domain (mutant) - mouse<br /> | ||
**[[3rrq]] - hCED-1 extracellular domain (mutant) - human<br /> | **[[3rrq]] - hCED-1 extracellular domain (mutant) - human<br /> | ||
**[[2m2d]] - hCED-1 extracellular domain - NMR<br /> | **[[2m2d]] - hCED-1 extracellular domain - NMR<br /> | ||
| Line 16: | Line 15: | ||
**[[5wt9]], [[5jxe]], [[5b8c]] - hCED-1 extracellular domain + antibody<br /> | **[[5wt9]], [[5jxe]], [[5b8c]] - hCED-1 extracellular domain + antibody<br /> | ||
**[[5ggs]], [[5ggr]] - hCED-1 extracellular domain (mutant) + antibody<br /> | **[[5ggs]], [[5ggr]] - hCED-1 extracellular domain (mutant) + antibody<br /> | ||
| + | **[[1npu]] – mCED-1 extracellular domain (mutant) - mouse<br /> | ||
**[[3bik]] - mCED-1 extracellular domain (mutant) + hCED-L1 extracellular domain<br /> | **[[3bik]] - mCED-1 extracellular domain (mutant) + hCED-L1 extracellular domain<br /> | ||
**[[3sbw]] - mCED-1 extracellular domain + hCED-L1 extracellular domain<br /> | **[[3sbw]] - mCED-1 extracellular domain + hCED-L1 extracellular domain<br /> | ||
| Line 32: | Line 32: | ||
*CED-4 | *CED-4 | ||
| - | **[[2a5y]] - CeCED-4 + CeCED-9 <BR /> | ||
| - | **[[3lqq]], [[3lqr]] - CeCED-4<BR /> | ||
**[[2ggf]] – hCED-4 MA3 domain – NMR<BR /> | **[[2ggf]] – hCED-4 MA3 domain – NMR<BR /> | ||
**[[2rg8]], [[2kzt]] - hCED-4 MA3 domain<BR /> | **[[2rg8]], [[2kzt]] - hCED-4 MA3 domain<BR /> | ||
| - | **[[2iol]], [[2ion]], [[2ios]], [[2nsz]] - mCED-4 MA3 domain<BR /> | ||
| - | **[[2hm8]] - mCED-4 MA3 domain – NMR<BR /> | ||
**[[3eij]] - hCED-4 residues 157-469<BR /> | **[[3eij]] - hCED-4 residues 157-469<BR /> | ||
**[[2zu6]], [[3eiq]] - hCED-4 residues 163-469 + eukaryotic initiation factor 4A-I<br /> | **[[2zu6]], [[3eiq]] - hCED-4 residues 163-469 + eukaryotic initiation factor 4A-I<br /> | ||
| + | **[[2iol]], [[2ion]], [[2ios]], [[2nsz]] - mCED-4 MA3 domain<BR /> | ||
| + | **[[2hm8]] - mCED-4 MA3 domain – NMR<BR /> | ||
**[[4m9s]], [[4m9x]], [[4m9y]], [[4m9z]] - nCED-4 + nCED-3 fragment<br /> | **[[4m9s]], [[4m9x]], [[4m9y]], [[4m9z]] - nCED-4 + nCED-3 fragment<br /> | ||
| + | **[[2a5y]] - CeCED-4 + CeCED-9 <BR /> | ||
| + | **[[3lqq]], [[3lqr]] - CeCED-4<BR /> | ||
*CED-5 | *CED-5 | ||
| Line 49: | Line 49: | ||
*CED-6 | *CED-6 | ||
| - | **[[1y1x]] - CED-6 – ''Leishmania major''<br /> | ||
| - | **[[1hqv]] - mCED-6<br /> | ||
**[[2zn8]], [[2zn9]], [[2znd]], [[2zrs]], [[2zrt]] - hCED-6<br /> | **[[2zn8]], [[2zn9]], [[2znd]], [[2zrs]], [[2zrt]] - hCED-6<br /> | ||
**[[3aaj]], [[3aak]] - hCED-6 (mutant)<br /> | **[[3aaj]], [[3aak]] - hCED-6 (mutant)<br /> | ||
| Line 56: | Line 54: | ||
**[[3wxa]] - hCED-6 + SEC31A peptide<br /> | **[[3wxa]] - hCED-6 + SEC31A peptide<br /> | ||
**[[5gqq]] - hCED-6 + heme-binding protein<br /> | **[[5gqq]] - hCED-6 + heme-binding protein<br /> | ||
| + | **[[1hqv]] - mCED-6<br /> | ||
| + | **[[1y1x]] - CED-6 – ''Leishmania major''<br /> | ||
*CED-8 (apoptosis-inducing factor 1) | *CED-8 (apoptosis-inducing factor 1) | ||
| - | **[[1gv4]], [[3gd3]] - mCED-8<br /> | ||
| - | **[[3gd4]] – mCED-8 + NAD <br /> | ||
| - | **[[5miu]] – mCED-8 (mutant) + FAD <br /> | ||
| - | **[[5miv]] – mCED-8 (mutant) + FAD + NAD<br /> | ||
**[[1m6i]], [[4bv6]], [[4lii]] - hCED-8<br /> | **[[1m6i]], [[4bv6]], [[4lii]] - hCED-8<br /> | ||
**[[5fmh]], [[5kvh]], [[5kvi]], [[5fs6]], [[5fs7]], [[5fs8]], [[4fdc]] – hCED-8 (mutant) <br /> | **[[5fmh]], [[5kvh]], [[5kvi]], [[5fs6]], [[5fs7]], [[5fs8]], [[4fdc]] – hCED-8 (mutant) <br /> | ||
**[[5fs9]] – hCED-8 (mutant) + FAD<br /> | **[[5fs9]] – hCED-8 (mutant) + FAD<br /> | ||
**[[4bur]] – hCED-8 + NAD <br /> | **[[4bur]] – hCED-8 + NAD <br /> | ||
| + | **[[1gv4]], [[3gd3]] - mCED-8<br /> | ||
| + | **[[3gd4]] – mCED-8 + NAD <br /> | ||
| + | **[[5miu]] – mCED-8 (mutant) + FAD <br /> | ||
| + | **[[5miv]] – mCED-8 (mutant) + FAD + NAD<br /> | ||
*CED-9 | *CED-9 | ||
Revision as of 06:52, 2 July 2020
| |||||||||||
3D structures of cell death protein
Updated on 02-July-2020
References
- ↑ Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, Domling A, Dubin G, Holak TA. Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. Structure. 2015 Oct 22. pii: S0969-2126(15)00402-5. doi:, 10.1016/j.str.2015.09.010. PMID:26602187 doi:http://dx.doi.org/10.1016/j.str.2015.09.010
- ↑ Lin DY, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3011-6. Epub 2008 Feb 14. PMID:18287011
